These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 16889095

  • 1. [Tuberculosis of the urinary bladder: diagnosis and treatment].
    Kul'chavenia EV, Brizhatiuk EV.
    Urologiia; 2006; (3):61-4, 66. PubMed ID: 16889095
    [Abstract] [Full Text] [Related]

  • 2. [Clinical trial to evaluate trospium chloride (Uraplex) effectiveness and tolerance in patients with detrusor instability incontinence and its impact on quality of life].
    Fuertes ME, García Matres MJ, González Romojaro V, de la Rosa S, Anguera Vila A, de la Peña J, Leiva Galvis O, Sánchez Chapado M.
    Arch Esp Urol; 2000 Mar; 53(2):125-36. PubMed ID: 10802918
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Multicenter phase III trial studying trospium chloride in patients with overactive bladder.
    Rudy D, Cline K, Harris R, Goldberg K, Dmochowski R.
    Urology; 2006 Feb; 67(2):275-80. PubMed ID: 16461077
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Obesity is associated with a more severe overactive bladder disease state that is effectively treated with once-daily administration of trospium chloride extended release.
    Chancellor MB, Oefelein MG, Vasavada S.
    Neurourol Urodyn; 2010 Apr; 29(4):551-4. PubMed ID: 19634167
    [Abstract] [Full Text] [Related]

  • 9. [Urogenital tuberculosis. Apropos of 40 cases].
    el Khader K, el Fassi J, Karmouni T, Tazi K, Ibnattya A, Hachimi M, Lakrissa A.
    Ann Urol (Paris); 1997 Apr; 31(6-7):339-43. PubMed ID: 9509233
    [Abstract] [Full Text] [Related]

  • 10. Comparison of intravaginal electrical stimulation and trospium hydrochloride in women with overactive bladder syndrome: a randomized controlled study.
    Ozdedeli S, Karapolat H, Akkoc Y.
    Clin Rehabil; 2010 Apr; 24(4):342-51. PubMed ID: 20212061
    [Abstract] [Full Text] [Related]

  • 11. Once-daily administration of trospium chloride extended release provides 24-hr coverage of nocturnal and diurnal symptoms of overactive bladder: an integrated analysis of two phase III trials.
    Ginsberg DA, Oefelein MG, Ellsworth PI.
    Neurourol Urodyn; 2011 Apr; 30(4):563-7. PubMed ID: 21268101
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Baseline incontinence severity is predictive of the percentage of patients continent after receiving once-daily trospium chloride extended release.
    Staskin DR, Cardozo L.
    Int J Clin Pract; 2009 Jun; 63(6):973-6. PubMed ID: 19459997
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Overactive bladder.
    Thacker HL, Paraiso M.
    Cleve Clin J Med; 2005 Jul; 72(7):544; author reply 544-5. PubMed ID: 16044651
    [No Abstract] [Full Text] [Related]

  • 20. [Trospium chloride (spasmex) in the treatment of lower urinary tract symptoms in patients with neurogenic hyperactive urinary bladder caused by vertebrogenic lesions].
    Mazo EB, Babanina GA.
    Urologiia; 2007 Jul; (3):15-9. PubMed ID: 17722614
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.